Making adjuvant therapy decisions with uncertain data

por Gyawali, B, Prasad, V
Publicado 2019

“The first ones now, will later be last”: understanding the importance of historical context when reading ESMO-MCBS scores

por Cherny, N.I., Dafni, U., Pentheroudakis, G., Piccart, M., Zygoura, P., Gyawali, B., de Vries, E.G.E.
Publicado 2022

Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment

por Weir, I R, Marshall, G D, Schneider, J I, Sherer, J A, Lord, E M, Gyawali, B, Paasche-Orlow, M K, Benjamin, E J, Trinquart, L
Publicado 2019

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

por Gyawali, B., de Vries, E.G.E., Dafni, U., Amaral, T., Barriuso, J., Bogaerts, J., Calles, A., Curigliano, G., Gomez-Roca, C., Kiesewetter, B., Oosting, S., Passaro, A., Pentheroudakis, G., Piccart, M., Roitberg, F., Tabernero, J., Tarazona, N., Trapani, D., Wester, R., Zarkavelis, G., Zielinski, C., Zygoura, P., Cherny, N.I.
Publicado 2021